Rationale: Pressure overload cardiac hypertrophy, a risk factor for heart failure, is associated with reduced mitochondrial fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS) proteins that correlate in rodents with reduced PGC-1␣ expression.
P GC-1␣ and PGC-1␤ are primarily expressed in oxidative tissues, including heart and skeletal muscle, and regulate mitochondrial biogenesis and genes encoding for enzymes of mitochondrial metabolism and proteins that compose the electron transport chain. [1] [2] [3] In nonstressed hearts from PGC-1␣-KO mice, impaired fatty acid oxidation (FAO) and oxidative phosphorylation (OXPHOS) gene expression were observed, but cardiac function was preserved. 4 Repression of PGC-1␣ and its transcriptional partners has been suggested as a potential mechanism responsible for the shift away from FAO toward glucose oxidation and impaired ATP production in pressure overload hypertrophy (POH) and heart failure. [5] [6] [7] Mice lacking PGC-1␣ show accelerated cardiac dysfunction and heart failure following POH. 8 Interestingly, loss of PGC-1␣ expression in nonstressed hearts reduced expression of FAO and OXPHOS genes to the same extent as aortic banding in control mice and in both instances without overt cardiac dysfunction. 8 However, in banded PGC-1␣-deficient hearts there was further repression of OXPHOS and FAO gene expression that coincided with the onset of heart failure. PGC-1␣-deficient hearts also exhibit increased oxidative stress in response to POH, which contributes to accelerated heart failure. 9 These observations suggest that a component of the mitochondrial dysfunction that occurs in the transition from compensated hypertrophy to heart failure might be PGC-1␣ independent and that a threshold expression of PGC-1␣ might be required to sustain mitochondrial function in compensated cardiac hypertrophy.
The role of PGC-1␤ and its contribution to cardiac mitochondrial and metabolic adaptations in nonstressed hearts and in response to POH is incompletely understood. We previously reported that PGC-1␤ deficiency reduces OXPHOS gene expression in the heart and reduced mitochondrial size. In isolated soleus muscle, absence of PGC-1␤ reduced electron transport chain gene expression, decreased mitochondrial volume density, and impaired mitochondrial oxygen consumption and ATP synthesis. 10 We therefore sought to determine whether PGC-1␤ contributed to the maintenance of mitochondrial and contractile function in response to POH induced by transverse aortic constriction (TAC). We observed that PGC-1␤ deficiency represses OXPHOS but not FAO gene expression in nonstressed hearts. PGC-1␤deficient hearts develop accelerated heart failure and greater mitochondrial dysfunction following POH. This is associated with increased oxidative stress and a more rapid decline in myocardial glucose utilization. A subset of OXPHOS genes was also identified whose expression levels are further repressed during POH in hearts that lack PGC-1␤. Thus, PGC-1␣ and PGC-1␤ play complementary but partially nonoverlapping roles in maintaining mitochondrial function in the hypertrophied and failing heart.
Methods
Animals PGC-1␤ Ϫ/Ϫ germ-line KO (␤KO) mice and wildtype (WT) littermate controls were generated as previously described. 10 The animals were housed at 22°C with a 12-hour light, 12-hour dark cycle with free access to water and standard chow (composition of chow is in the Online Supplement, available at http://circres.ahajournals.org). Studies were performed in mice of both genders as indicated in the figure legends. All animal experiments were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of the University of Utah.
Surgeries
Transverse aortic constriction (TAC) was performed at the age of 8 to 10 weeks or at 23 to 30 weeks using methods previously described. 11 Animals were euthanized either 3 or 8 weeks after surgery. See Online Supplement for surgical details.
Transthoracic Echocardiography
Mouse echocardiography was performed as previously described. 12 Efficacy of the aortic ligation was determined by comparing flow velocity in right and left carotid arteries using pulsed-wave Doppler. Full details are provided in the Online Supplement.
Hemodynamic Studies
Heart rate, left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), and the maximal rate of pressure change (ϩdP/dt and ϪdP/dt) were recorded and analyzed as previously described, 13 following insertion of a micromanometer-tipped pressure catheter (Millar Instruments, Houston, TX) that was retrogradely introduced into the left ventricle (LV) via the right carotid artery. Studies were performed in nonstressed mice before and after dobutamine 10 and following 3 or 8 weeks of TAC or sham surgery. Detailed methods are summarized in the Online Supplement.
Isolated Working Hearts
Cardiac substrate metabolism, left ventricular developed pressure, cardiac output, cardiac power, oxygen consumption, and cardiac efficiency were measured in isolated working hearts obtained after 3 weeks of banding as previously described. 14 Hearts were perfused with 5 mmol/L glucose and 0.4 mmol/L palmitate without insulin.
Mitochondrial Function
Mitochondrial oxygen consumption and ATP production rates were measured in ventricular muscle fibers as described before, with palmitoyl carnitine or pyruvate as substrate. 15 See Online Supplement for details.
RNA Extraction and Quantitative RT-PCR
Total RNA was isolated, reverse transcribed to cDNA, which was quantified by real-rime PCR as previously described and transcript levels normalized to cyclophilin A. 16 Primer sequences and accession numbers are listed in Online Table I . See Online Supplement for detailed methods.
Western Blot Analysis
Immunoblotting was performed with heart homogenates as described in the Online Supplement.
Electron Microscopy
Left ventricular samples were prepared for electron microscopy as previously described. 17 Mitochondrial number and volume density were assessed in a blinded fashion using point quantification counting. 18 For volume density, 2 pictures per sample were analyzed using 2 grids per picture. For mitochondrial number, 3 pictures per sample were analyzed.
Measurement of ROS Levels
Reactive oxygen species levels were measured by 2Ј-7Јdichlorofluorescein-diacetate (DCFDA) fluorescence as described in the Online Supplement. 
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Statistical Analysis
Statistical analysis is described in the Online Supplement. Data are presented as meansϮSEM. RT-PCR results are presented as fold change versus WT sham. A probability value of Ͻ0.05 was considered significantly different.
Results
Inotropic Reserves in PGC-1␤ ؊/؊ Hearts
LV hemodynamics was determined in PGC-1␤ Ϫ/Ϫ (␤KO) and wildtype (WT) hearts as a function of age. As shown in Figure 1A , peak rates of ventricular contraction (ϩdP/dt) were significantly higher in 7-week-old WT hearts, after which an age-dependent decline was observed. By contrast, despite an initial reduction, no age-related decline in ϩdP/dt was observed in ␤KO hearts, so that by 17 and 27 weeks of age, respectively, there were no significant differences between the genotypes. Similar patterns were observed for LV developed pressure (LVDevP) and peak rates of ventricular relaxation (ϪdP/dt) (data not shown). To determine whether the reduction in contractility in 7-week-old ␤KO hearts was associated with decreased contractile reserve, hemodynamic measurements were performed following administration of a graded infusion of dobutamine. Heart rates were similar at baseline, but ␤KO mice developed a blunted chronotropic response ( Figure 1B ). By contrast, the fold change (from respective baselines) in LVDevP and ϮdP/dt was similar in ␤KO and WT hearts ( Figure 1C and 1D). Because baseline values were lower in ␤KO than WT, absolute values remained lower in ␤KO throughout the dobutamine infusion.
Increased Left Ventricular Dysfunction After TAC in PGC-1␤ ؊/؊ Hearts
TAC was performed in mice at 2 ages (8 to 10 weeks of age and 23 to 30 weeks of age). The first cohort was studied after 8 weeks of TAC (age 16 to 18 weeks) and the second cohort after 3 weeks of TAC (age 26 to 33 weeks of age). At these ages, there were no differences in in vivo hemodynamics between KO and WT sham-operated mice ( Figure 1A) . In sham-operated hearts, heart weights of ␤KO mice were similar to those of WT mice and exhibited no histological abnormalities. After 8 weeks of TAC, WT and ␤KO hearts developed comparable degrees of hypertrophy (Figure 2A through 2C and Online Table II) , and similar increases in mean cardiomyocyte cross-sectional surface area ( Figure 2D through 2F). However, ␤KO hearts developed increased fibrosis, independent of any increase in TUNEL-positive nuclei ( Figure 2E and 2G through 2I). We also analyzed left ventricular function at 3 and 8 weeks following TAC. Three weeks following TAC, WT and ␤KO hearts exhibited modest degrees of left ventricular (LV) dysfunction as evidenced by LV dilation. However, these changes were not statistically different between banded WT and banded ␤KO ( Figure 3B ). Moreover, fractional shortening was not different from that in sham-operated animals ( Figure 3B and Online Table III ). LV function progressively declined as evidenced by decreased ejection fraction (EF) and fractional shortening (FS) in ␤KO and WT mice between 3 and 8 weeks post-TAC ( Figure 3B and 3C). Thus after 8 weeks of TAC, the degree of reduction of EF and FS was greater in PGC-1␤ KO hearts, which developed overt heart failure as evidenced by decreased left ventricle systolic pressure (LVSP), impaired peak rates of ventricular contraction, and relaxation (ϮdP/dt) and increased left ventricular cavity dimensions ( Figure 3A , 3C, and 3D).
Mitochondrial Dysfunction Following TAC in WT and PGC-1␤ KO Hearts
Mitochondrial function was determined after 8 weeks of TAC ( Figure 4A and 4B). With pyruvate as a substrate, maximal ADP-stimulated mitochondrial oxygen consumption (V ADP ) and ATP synthesis rates were unchanged in sham-operated ␤KO and were decreased equivalently following TAC in both WT and ␤KO mice. Palmitoyl-carnitine (PC)-supported V ADP and ATP synthesis were decreased in sham-operated ␤KO mice, and TAC reduced PC-supported V ADP and ATP synthesis in WT hearts to levels that were similar to sham ␤KO. TAC modestly reduced V ADP in ␤KO further so that in relation to WT-TAC, V ADP was significantly reduced. ATP synthesis rates followed a similar pattern, but the decline in ATP synthesis in ␤KO after TAC was more pronounced, being lowest in ␤KO-TAC mice in relation to all other groups ( Figure 4B ). Mitochondrial dysfunction was not associated with any noticeable change in mitochondrial ultrastructure, number, or volume density (Online Figure I ). To determine whether the decline in mitochondrial function induced by TAC was associated with independent evidence of energetic stress, we determined AMPK phosphorylation, which was significantly increased in the banded ␤KO after 8 weeks of TAC, but not in banded WT ( Figure 4C ).
Oxidative Stress Is Increased in Banded PGC-1␤ ؊/؊ Hearts
To gain additional insight into the mechanisms that increased heart failure progression in banded ␤KO mice, we evaluated the potential contribution of oxidative stress. Total levels of tissue ROS were increased in banded ␤KO hearts 3 and 8 weeks after TAC, respectively ( Figure 5A and 5B). Pressure overload was associated with repression of MnSOD protein after 3 weeks of banding in ␤KO but not in banded WT hearts. After 8 weeks of banding, MnSOD was equivalently repressed in banded mice of both genotypes ( Figure 5C ). Thus loss of antioxidant capacity occurs at an earlier stage after pressure overload in ␤KO mice. Uncoupling proteins, such as UCP3, mediate reduction of membrane potential under conditions of increased ROS. 20 UCP3 protein levels were increased in sham ␤KO mouse hearts in relation to sham WT. Banding equivalently repressed UCP3 in both genotypes at 3 and 8 weeks following TAC, which paralleled changes in UCP3 mRNA (Figure 7 and Online Figure II ).
Substrate Metabolism and Cardiac Efficiency in PGC-1␤ ؊/؊ Hearts Following TAC
Substrate metabolism was determined in isolated working hearts, 3 weeks after sham or banding surgery. In relation to WT shams, TAC increased glucose oxidation and glycolysis rates in WT hearts. Rates of glucose oxidation and glycolysis were also increased in nonstressed ␤KO hearts. However, in response to banding there was a significant reduction both in glucose oxidation and glycolysis to levels that were lower than WT-TAC. Palmitate oxidation rates were not altered by banding in WT hearts. By contrast, FAO was increased in ␤KO hearts and tended to fall with banding (Pϭ0.08), but did not fall below WT levels ( Figure 6 ). Left ventricular developed pressure, cardiac output, cardiac power, oxygen consumption, and cardiac efficiency were also determined in isolated working hearts. In sham-operated hearts, there were no differences in cardiac function, but myocardial oxygen consumption rates (MVO 2 ) were increased in ␤KO hearts, resulting in decreased cardiac efficiency. LV-developed pressure declined with banding in both genotypes but to a greater extent in ␤KO. Cardiac output and cardiac power declined equivalently in banded mice of both genotypes. MVO 2 remained persistently increased in banded ␤KO hearts leading to a greater reduction in cardiac efficiency in banded ␤KO in relation to banded WT. Thus, PGC-1␤ deficiency leads to diminished glucose utilization and decreased cardiac efficiency following TAC.
Changes in Expression of Metabolic Regulators Following Banding in PGC-1␤ ؊/؊ Hearts
Targeted gene expression analysis was performed to evaluate the impact of TAC versus loss of PGC-1␤ on mitochondrial †PϽ0.05 versus WT same treatment (nϭ6 to 13). Weeks 1 to 3 mice were banded at 23 to 30 weeks of age and week 8 data are from 16-to 18-week-old mice. and metabolic genes (Figure 7 and Online Figure II) . In WT mice, TAC leads to reduced expression of PGC-1␣, OX-PHOS, and FAO genes as early as 3 weeks after banding and reduced expression of PGC-1␤ by 8 weeks. Similar reductions of PGC-1␣ and PGC-1␤ mRNA expression, and their downstream targets, involved in OXPHOS and FAO was also observed in rat hearts following 2 weeks of TAC (Online  Tables IV and V) , indicating a conserved transcriptional response of mitochondrial regulatory genes to POH in 2 rodent species. After 3 weeks of TAC, expression levels of PGC-1␤ were increased in WT, and expression of PPAR␣ and PGC-1␣ were equivalently reduced by 30% and 60%, respectively, in ␤KO and WT. OXPHOS gene expression was globally reduced in sham-operated ␤KO, which mirrored the pattern observed in WT-TAC, suggesting redundant roles for PGC-1␣ and PGC-1␤ in the regulation of these genes. For the majority of the OXPHOS genes examined, there was no further reduction in expression levels following TAC in ␤KO mice despite additional reductions in PGC-1␣ expression. By contrast, 3 OXPHOS genes (ndfua9, cox4i, and cox5b) were additionally repressed in ␤KO after TAC, suggesting synergistic interactions of PGC-1␣ and PGC-1␤ in the regulation of these genes. KO of PGC-1␤ had no impact on FAO gene expression in nonstressed hearts. In contrast, FAO gene expression was reduced equivalently in WT and ␤KO hearts after 3 weeks of TAC. Thus, impaired FAO gene expression following TAC is most likely the consequence of reduced levels of PGC-1␣ and PPAR␣. Similar patterns of gene expression were noted following 8 weeks of TAC, but in addition, reduced expression of PGC-1␤ occurred in WT-TAC. In nonstressed ␤KO hearts, expression levels of most glucose regulatory genes were unchanged, with the exception of the alpha subunit of PDH (PDHA1), which was reduced in sham ␤KO hearts. With the exception of HIF-1␣ mRNA, which was induced by banding in WT and ␤KO, most genes involved in glucose metabolism were equivalently repressed by banding in WT and ␤KO. GLUT1 exhibited a biphasic response, initially being repressed by banding at 3 weeks, but induced by 8 weeks in both WT and ␤KO. We also examined the protein levels of GLUT4 and hexokinase II, and assessed the phosphorylation state of PDH. Banding repressed GLUT4 content in WT and ␤KO hearts ( Figure 7B ). The phosphorylation of the PDH-E1␣ subunit was unchanged in all groups, with the exception of banded ␤KO hearts at 3 and 8 weeks, respectively, where the phosphorylation of this subunit was reduced ( Figure 7C and Online Figure II ). Hexokinase II (HKII) protein was induced in WT hearts after 8 weeks of banding and was increased in sham ␤KO hearts in the 8-week cohort. However, after 8 weeks there was a significant reduction in HKII protein in ␤KO following TAC ( Figure 7D ).
Discussion
The present study identified important roles for PGC-1␤ in the maintenance of cardiac OXPHOS gene expression and mitochondrial function in nonstressed hearts and cardiac function following pressure overload hypertrophy (POH). PGC-1␤ plays an important role in maintaining cardiac function in compensated POH, as evidenced by the increased susceptibility of PGC-1␤ deficient hearts to heart failure. The mechanisms by which PGC-1␤ contributes to the maintenance of cardiac function in response to pressure overload are complex and cannot be completely accounted for by changes in the expression of nuclear genes that regulate mitochondrial OXPHOS, FAO, or glucose metabolism, given the similarity in the transcriptional responses of banded WT and KO mice. Moreover, we identify some circumstances in which changes in gene expression do not necessarily correlate with changes at the protein levels as exemplified by hexokinase II in banded PGC-1␤ KO hearts. Rather, a number of defects became apparent with banding in PGC-1␤ deficient hearts that include increased oxidative stress that may be precipitated in part by an early loss of antioxidant defenses, a precipitous reduction in glucose utilization, and reduced cardiac efficiency that precede the subsequent decline in cardiac function. By the time that heart failure ensues, additional defects were noted in ␤ KO hearts such as decreased palmitoyl carnitine ATP generation, increased AMPK phosphorylation, and decreased HKII content. It is, however, challenging to discern whether these additional molecular defects are a cause or a consequence of the more severe heart failure in ␤ KO hearts.
In nonstressed hearts, no differences in heart weights were observed between WT and ␤KO mice, and expression of natriuretic peptide precursor types A and B were unchanged. At the ages at which the banded hearts were analyzed, there were no differences in contractile function between shamoperated ␤KO and WT, which is consistent with previous reports. 10, 21 Interestingly, however, in young ␤ KO mice a reduction in basal contractility was observed, suggesting that deficiency of PGC-1␤ led to a constitutive defect in contractile function that did not progress with age. Importantly, inotropic reserve in response to dobutamine was relatively preserved in young ␤ KO mouse hearts, which supports observations by Lai et al, who reported that LV contractile function following exercise was not impaired in ␤ KO mice of similar age. 21 We confirmed a defect in chronotropic reserve in young ␤ KO mice that we previously observed in an older cohort of mice. 10 However, there were no differences in heart rate following banding in ␤ KO mice. Taken together, these data suggest that PGC-1␤ plays an important role in preserving LV function in response to pressure overload. However, we cannot completely rule out the possibility that this constitutive defect could contribute in part to the more rapid decline in cardiac function when pressure overload was imposed. Cardiac phenotypes have been described for 2 independently generated lines of PGC-1␣ KO mice. One model showed normal contractile function under basal conditions 4, 22 and the other exhibited age-dependent contractile dysfunction. 23 Deletion of PGC-1␣, results in impaired expression of both FAO and OXPHOS genes in nonstressed hearts. 4 In contrast, we observed that whereas PGC-1␤ plays an important role in the regulation of OXPHOS gene expression, it does not appear to be necessary for regulating FAO genes, suggesting divergent roles for PGC-1 isoforms in regulating FAO gene expression. Similar changes Figure 2) . B-D, Western blot analysis and densitometric ratios of GLUT4 protein expression, PDH-E1␣ phosphorylation, and hexokinase II protein expression in WT and KO hearts 8 weeks postsurgery (nϭ5 to 6, same mice as Figure 5 ). *PϽ0.05 versus sham same genotype. †PϽ0.05 versus WT same treatment. Gene names are shown in Online Table III. in mitochondrial gene expression were noted in the hearts of 2 other independently generated PGC-1␤ deficient mouse models. 21, 24 Importantly, repression of OXPHOS and FAO gene expression in these models is not sufficient to consistently impair cardiac function in the nonstressed heart.
Deficiency of PGC-1␣ in the heart reduces maximal palmitoyl-carnitine (PC)-supported (V ADP ) respiration and increases pyruvate-supported V ADP respiration. 4 In the present study, we observed impaired PC-supported V ADP respiration and ATP synthesis in nonstressed hearts lacking PGC-1␤. But in contrast to PGC-1␣-KO (␣ KO) hearts, KO of PGC-1␤ had no effect on pyruvate-supported mitochondrial function. The basis for the differences in pyruvatesupported respiration in ␣ versus ␤ KO mice is not fully understood. We speculate that because PGC-1␣ deficiency significantly represses OXPHOS and FAO gene expression, there is a greater reliance of ␣ KO mitochondria on glucose carbons, which drives adaptive responses that increase pyruvate utilization. In this regard, we observed a reduction in expression levels of the PDHA1 subunit in sham ␤ KO hearts, which could also limit the induction of pyruvate utilization. In contrast, there was no repression of FAO genes in ␤ KO hearts, nor was there any defect in FA utilization in isolated working hearts. PC-supported respiration and ATP synthesis rates were reduced in ␤ KO mitochondria. However, the reductions were not as striking as we previously reported in ␣ KO mitochondria in which PC-supported ATP generation was reduced by 65%, 4 which contrasts with the 30% reduction in ␤ KO mitochondrial ATP synthesis observed in the present study. These findings are consistent with the hypothesis that the greater decline in mitochondrial function with FA substrates in ␣ KO mice reflects the combined effects of reduced OXPHOS and FAO capacity. Electron microscopy revealed normal mitochondrial volume density and number for nonstressed PGC-1␤ deficient hearts, which is consistent with previous reports that examined younger PGC-1␤ KO hearts. 21 It is important to note, though, that mitochondrial volume density declines with age in PGC-1␤ KO hearts. 10 Thus analyses of nonstressed ␤KO hearts reveal divergent effects for PGC-1␣ versus PGC-1␤ on the expression of mitochondrial metabolic genes and mitochondrial function. However, both of these models suggest that mitochondrial dysfunction that develops on the basis of loss of either PGC-1␣ or PGC-1␤ is not sufficient to impair cardiac function throughout life in the absence of a superimposed stress. They also support the existence of overlapping or redundant roles for both of these transcriptional regulators in the regulation of nuclear-encoded genes that regulate mitochondrial metabolism and suggest that loss of PGC-1␣ may compensate for the loss of PGC-1␤ in maintaining contractile function under nonstressed conditions, and vice versa. Support for redundant roles for PGC-1␣ and PGC-1␤ in maintaining basal mitochondrial function in the heart was also provided by analysis of mice that lack both PGC-1␣ and PGC-1 ␤, which die of heart failure shortly after birth with bradycardia, small hearts, and reduced cardiac output. 21 We examined the impact of PGC-1␤ deletion on pressureoverload cardiac hypertrophy (POH). PGC-1␤ KO mice progressed more rapidly to heart failure than did banded WT mice, and this was clearly associated with evidence of energetic stress, namely increased phosphorylation of AMPK. An earlier study demonstrated that mice lacking PGC-1␣ developed heart failure 8 weeks following TAC. This was associated with additional repression of FAO and OXPHOS genes in PGC-1␣-KO mice in response to TAC, versus WT-TAC or sham-operated PGC-1␣-KO mice. 8 It is important to note that the additional repression of OXPHOS and FAO gene expression in banded PGC-1␣-KO mice occurred despite normal expression of PGC-1␤. These data suggest that PGC-independent mechanisms must exist that account for reduced expression of mitochondrial target genes in pressure-overload hypertrophy. They also suggest that there is a critical threshold of mitochondrial activity that is required to cope with increased workload, which cannot be substituted for or sustained by PGC-1␤. The transition to heart failure was not associated with striking changes in mitochondrial morphology in ␤ KO hearts. Although unexpected, it is probable that ultrastructural studies were performed at a time point shortly after the transition to heart failure and that a longer period of observation might be needed before changes in mitochondrial morphology become apparent.
It is also likely that energetic limitations might not be the only mechanism that contributed to heart failure in PGC-1␣ and PGC-1␤ KO hearts following TAC. A recent study in banded PGC-1␣-KO mice suggested that increased oxidative stress partially drove the LV dysfunction that was observed. 9 In the present study we also obtained evidence of significant oxidative stress that developed in PGC-1␤ KO hearts and was evident as early as 3 weeks post-TAC, prior to any differences in LV function. In this regard, it is interesting to note that protein levels of MnSOD were significantly repressed as early as 3 weeks in banded PGC-1␤ KO hearts but not in banded WT hearts in which repression of MnSOD was only evident after 8 weeks. It is also noteworthy that preserved MnSOD content, 3 weeks post-TAC, correlated with increased PGC-1␤ expression, despite reduced PGC-1␣ expression in WT hearts, whereas at 8 weeks, the expression of PGC-1␣ and ␤ were both reduced in banded WT hearts. Taken together, these data indicate that PGC-1␤ plays an important role in supporting antioxidant mechanisms that may limit oxidative stress in the compensated state of pressure-overload cardiac hypertrophy and represents another function that overlaps with that of PGC-1␣.
Interesting changes were observed in the expression levels and content of uncoupling proteins, which could also contribute to the cardiac responses observed. UCP3 protein and mRNA were increased in sham ␤ KO hearts, and were repressed by TAC in KO and WT hearts. UCP2 mRNA also exhibited a similar pattern. Uncoupling proteins have been proposed to play a role in reducing mitochondrial membrane potential under conditions in which ROS is increased. 20 Thus the increase in UCP2 and UCP3 in the PGC-1␤-deficient hearts could reflect an adaptation to low levels of oxidative stress that might also be present in nonstressed ␤ KO hearts. The increase in UCPs could also contribute to the increase in MVO 2 and reduced cardiac efficiency that characterized these hearts. ROS are potent activators of uncoupling proteins; thus the persistently elevated MVO 2 in banded ␤ KO hearts could represent ROS-mediated activation of UCPs in the face of progressive oxidative stress, despite falling levels of UCPs following TAC. Isolated working hearts revealed significant differences in substrate utilization between PGC-1␤-deficient hearts and WT controls. As reported by others, compensated LVH in wildtype hearts was associated with increased glucose utilization. Unexpectedly, glucose and FA utilization was increased in nonstressed ␤ KO hearts. The molecular mechanisms for these adaptations are not immediately apparent, and will require additional studies in the future. Importantly, these adaptations were not sustained in ␤ KO hearts following TAC. The global reduction in glucose utilization is not accounted for by differences in GLUT4 protein or by increased phosphorylation of PDH. There is the suggestion that hexokinase II (HKII) levels might fall more rapidly in banded ␤ KO hearts and could contribute to decreased glucose utilization, although it is likely that additional mechanisms are also involved. An association between HKII and VDAC in mitochondria plays an important role in cardioprotection. 25 We did not measure mitochondrial localization of HKII in response to banding in ␤ KO hearts. If the decline in HKII in whole-heart homogenates parallels a decline in mitochondrial HKII, this could potentially contribute to exacerbated mitochondrial dysfunction.
Our results support a model that PGC-1␣ and PGC-1␤ play partially overlapping but somewhat distinct roles in maintaining cardiac mitochondrial energetics in the unstressed heart with both pathways regulating the expression of OXPHOS genes, whereas PGC-1␣ predominantly regulates FAO capacity. Both PGC-1 isoforms likely contribute to the maintenance of cardiac function in the context of pressure overload. Although it is clear that PGC-1␣ expression is repressed much earlier in the course of POH than is PGC-1␤, it seems that the heart can at least in the short term tolerate a 50% reduction of PGC-1␣ and complete absence of PGC-1␤, with relative preservation of LV function as was observed at 3 weeks. However, changes in patterns of substrate utilization and evidence of oxidative stress were already present at this stage, implying that maladaptation as a result of reduced expression of these coactivators likely contributed to the subsequent development of heart failure. The time course for the development of overt heart failure in PGC-1␣ and PGC-1␤ KO hearts after TAC are remarkably similar, implying that there is reserve mitochondrial capacity that is capable of maintaining myocardial energetics and contractile function in the face of reduced expression or activity of these transcriptional coactivators. Moreover, our study underscores the potential role of additional mechanisms such as oxidative stress that is exacerbated by deficiency of these transcriptional coactivators that likely contributes to the accelerated transition to decompensated heart failure.
In conclusion, the present study describes the contribution of PGC-1␤ to mitochondrial function and gene expression in nonstressed hearts and identifies its contribution to maintaining contractile function under pathological increased workload. Thus, modulation of PGC-1 activity may represent a promising target for limiting the transition from pressureoverload cardiac hypertrophy to heart failure.
